154 related articles for article (PubMed ID: 31819404)
1. Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis.
Zheng JP; Zhang J; Ma LJ; Chen P; Huang M; Ou XM; Zhao ZW; Jiang SJ; Cao J; Yao W
Int J Chron Obstruct Pulmon Dis; 2019; 14():2725-2731. PubMed ID: 31819404
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Zhang R; Zhu J; Liu Y; Li Y; Liu W; Zhang M; Chen B; Zhu S
Int J Chron Obstruct Pulmon Dis; 2020; 15():409-415. PubMed ID: 32161453
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China.
Zhang J; Yao W; You X; Liu T; Liu Y
Int J Chron Obstruct Pulmon Dis; 2019; 14():1195-1207. PubMed ID: 31213797
[No Abstract] [Full Text] [Related]
4. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.
Ding Z; Li X; Lu Y; Rong G; Yang R; Zhang R; Wang G; Wei X; Ye Y; Qian Z; Liu H; Zhu D; Zhou R; Zhu K; Ni R; Xia K; Luo N; Pei C
Respir Med; 2016 Dec; 121():39-47. PubMed ID: 27888990
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacies of nebulized budesonide and systemic corticosteroids in the treatment of exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Gu YL; Pang J; Sun ZX; Hu J; Sun Y; Wu XW; Guo JJ; Yang GS
J Clin Pharm Ther; 2020 Jun; 45(3):419-429. PubMed ID: 31954070
[TBL] [Abstract][Full Text] [Related]
6. Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study.
Zhang J; Zheng J; Huang K; Chen Y; Yang J; Yao W
Ther Adv Respir Dis; 2018; 12():1753466618769514. PubMed ID: 29692212
[TBL] [Abstract][Full Text] [Related]
7. Nebulized Corticosteroids in the Treatment of COPD Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective.
Pleasants RA; Wang T; Xu X; Beiko T; Bei H; Zhai S; Drummond MB
Respir Care; 2018 Oct; 63(10):1302-1310. PubMed ID: 30237276
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis.
Chen Y; Liu Y; Zhang J; Yao W; Yang J; Li F; Lu L; Zheng J; Han X; Xu JF
Int J Chron Obstruct Pulmon Dis; 2020; 15():2343-2353. PubMed ID: 33061352
[TBL] [Abstract][Full Text] [Related]
9. Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD.
Calverley PM; Eriksson G; Jenkins CR; Anzueto AR; Make BJ; Persson A; Fagerås M; Postma DS
Int J Chron Obstruct Pulmon Dis; 2017; 12():13-25. PubMed ID: 28031707
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
[TBL] [Abstract][Full Text] [Related]
11. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.
Maltais F; Ostinelli J; Bourbeau J; Tonnel AB; Jacquemet N; Haddon J; Rouleau M; Boukhana M; Martinot JB; Duroux P
Am J Respir Crit Care Med; 2002 Mar; 165(5):698-703. PubMed ID: 11874817
[TBL] [Abstract][Full Text] [Related]
13. Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies.
Hollis S; Jorup C; Lythgoe D; Martensson G; Regnell P; Eckerwall G
Int J Chron Obstruct Pulmon Dis; 2017; 12():1071-1084. PubMed ID: 28435240
[TBL] [Abstract][Full Text] [Related]
14. [Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation molecules].
Makarova EV; Varvarina GN; Menkov NV; Czapaeva MY; Lazareva ES; Kazatskaya ZA; Novikov VV; Karaulov AV
Ter Arkh; 2016; 88(3):24-31. PubMed ID: 27030325
[TBL] [Abstract][Full Text] [Related]
15. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
[TBL] [Abstract][Full Text] [Related]
16. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results.
Fukuchi Y; Samoro R; Fassakhov R; Taniguchi H; Ekelund J; Carlsson LG; Ichinose M
Respirology; 2013 Jul; 18(5):866-73. PubMed ID: 23551359
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting.
Perrone V; Sangiorgi D; Buda S; Degli Esposti L
Int J Chron Obstruct Pulmon Dis; 2016; 11():2749-2755. PubMed ID: 27853362
[TBL] [Abstract][Full Text] [Related]
18. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
19. Inhaled steroids in exacerbations of COPD.
Singh A
Eur Respir J; 2007 Aug; 30(2):398; author reply 399-400. PubMed ID: 17666566
[No Abstract] [Full Text] [Related]
20. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
